|  | 
| MechanismADRA2 antagonists | 
|  | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhasePhase 1 | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
|  | 
| MechanismADRA2 antagonists | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhaseDiscontinued | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
100 Clinical Results associated with Potomac Doo
0  Patents (Medical) associated with Potomac Doo
100 Deals associated with Potomac Doo
100 Translational Medicine associated with Potomac Doo